The effect of laser therapy on MMP-13 level during periodontal treatment
Not Applicable
- Conditions
- chronic periodontitis.Chronic periodontitis
- Registration Number
- IRCT20140318017053N9
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
systemic health
Having 16 teeth or more
Exclusion Criteria
smoking
pregnancy
breast-feeding
use of drugs (corticostroid, anti-biotic, immuno-suppressive)
periodontal therapy during the last 6 months.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical attachment level. Timepoint: base-line , 2 and 6 months after phase I periodontal therapy. Method of measurement: periodontal probe.;Matrix metalloproteinase-13. Timepoint: base-line , 2 and 6 months after phase I periodontal therapy. Method of measurement: ELISA test.
- Secondary Outcome Measures
Name Time Method Pocket depth. Timepoint: base-line , 2 and 6 months after phase I periodontal therapy. Method of measurement: periodontal probe.;Bleeding on probing. Timepoint: base-line , 2 and 6 months after phase I periodontal therapy. Method of measurement: periodontal probe.